Related Experiment Video
Updated: Jan 19, 2026
Open Angle Glaucoma: Treatment
Update on the genetics of primary open-angle glaucoma
Hannah Youngblood1, Michael A Hauser2, Yutao Liu3
1Department of Cellular Biology and Anatomy, Augusta University, 1460 Laney Walker Blvd CB1101, Augusta, GA, 30912, United States.
Glaucoma, a leading cause of irreversible blindness, involves optic nerve damage. Genetic research is crucial for understanding and treating primary open-angle glaucoma (POAG) and its progression.
Area of Science:
- Ophthalmology
- Genetics
- Genomics
Background:
- Glaucoma is a leading cause of irreversible blindness globally, affecting millions.
- Primary open-angle glaucoma (POAG) is the most common form, characterized by optic nerve damage and vision loss.
- Key risk factors include elevated intraocular pressure, aging, ancestry, and family history.
Purpose of the Study:
- To explore the genetic underpinnings of POAG.
- To identify novel genetic loci and understand gene expression patterns in POAG.
- To enhance diagnostic and therapeutic strategies for this complex genetic eye disease.
Main Methods:
- Genome-wide association studies (GWAS) to identify genetic loci.
- Genomic and proteomic profiling of biofluids for gene expression analysis.
- Functional studies in cell and animal models, alongside in silico analyses.
Main Results:
- Identification of numerous novel genetic loci associated with POAG and its endophenotypes.
- Characterization of differential gene expression in POAG through biofluid profiling.
- Confirmation of variant effects and gene expression impacts on ocular physiology.
Conclusions:
- Genomic research has significantly advanced the understanding of POAG.
- Further investigation into genetic factors is essential for improved diagnosis and treatment.
- Integrating genetic insights with functional and computational studies offers a path toward managing POAG.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
03:04Experimental Glaucoma Induction via Iridocorneal Angle Obstruction In a Mouse Model
07:11Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
05:05Ultrasound Cyclo Plasty in Eyes with Glaucoma
04:07Genetic Modification of Primary Human Keratinocytes: A Method for Genetically Manipulating Keratinocytes Using Recombinant Retroviruses

